These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 25620758)
1. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758 [TBL] [Abstract][Full Text] [Related]
2. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051 [TBL] [Abstract][Full Text] [Related]
3. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients. Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352 [TBL] [Abstract][Full Text] [Related]
5. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients. Schnaidt M; Northoff H; Wernet D Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957 [TBL] [Abstract][Full Text] [Related]
6. [Platelet transfusion refractoriness and effective management of platelet alloimmunization]. Amemiya Y Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306 [TBL] [Abstract][Full Text] [Related]
7. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients. Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715 [TBL] [Abstract][Full Text] [Related]
8. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A; Picard C Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [TBL] [Abstract][Full Text] [Related]
9. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Lo SC; Chang JS; Lin SW; Lin DT Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666 [TBL] [Abstract][Full Text] [Related]
10. Platelet alloantibodies in transfused patients. Kiefel V; König C; Kroll H; Santoso S Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817 [TBL] [Abstract][Full Text] [Related]
11. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients]. Schnaidt M; Wernet D; Mayer G; Northoff H Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099 [TBL] [Abstract][Full Text] [Related]
13. Alloimmunization against human platelet antigen 2 (HPA2) in a series of multi-transfused beta-thalassemia patients. Tazzari PL; Ricci F; Tassi C; Bontadini A; Fruet F; Conte R Haematologica; 1998 Aug; 83(8):765-6. PubMed ID: 9793272 [TBL] [Abstract][Full Text] [Related]
14. A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Castro V; Kroll H; Origa AF; Falconi MA; Marques SB; Marba ST; Passini R; Annichino-Bizzacchi JM; Costa FF; Santoso S; Arruda VR Transfusion; 2007 Jan; 47(1):59-66. PubMed ID: 17207231 [TBL] [Abstract][Full Text] [Related]
15. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies. Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262 [TBL] [Abstract][Full Text] [Related]
16. A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation. Campbell K; Rishi K; Howkins G; Gilby D; Mushens R; Ghevaert C; Metcalfe P; Ouwehand WH; Lucas G Vox Sang; 2007 Nov; 93(4):289-97. PubMed ID: 18070271 [TBL] [Abstract][Full Text] [Related]
17. The relevance of HPA-15 antigen expression for anti-HPA-15 antibody detection. Maślanka K; Michur H; Guz K; Wróbel A; Uhrynowska M; Misiak A; Ejduk A; Brojer E; Zupańska B Int J Lab Hematol; 2012 Feb; 34(1):65-9. PubMed ID: 21752233 [TBL] [Abstract][Full Text] [Related]
18. Use of HLA- and HPA--matched platelets in alloimmunized patients. Kekomäki R Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468 [TBL] [Abstract][Full Text] [Related]
19. The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients. Matsuhashi M; Tsuno NH; Sone S; Mishima Y; Nagura Y; Watanabe-Okochi N; Ikeda T; Kashiwase K; Fukuda S; Iriyama T; Hyodo H; Yamashita T; Kamei Y; Arai S; Minami M; Fujii T; Kurokawa M; Tozuka M; Takahashi K; Santoso S Transfusion; 2014 Apr; 54(4):1093-9. PubMed ID: 24147542 [TBL] [Abstract][Full Text] [Related]
20. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders. Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]